Navigating the ERK1/2 MAPK Cascade

被引:32
|
作者
Martin-Vega, Ana [1 ]
Cobb, Melanie H. [1 ,2 ]
机构
[1] UT Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, 6001 Forest Pk Rd, Dallas, TX 75390 USA
关键词
ERK1/2; MAPKs; cancer; scaffold; therapies; inhibitors; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; EPIDERMAL-GROWTH-FACTOR; SELECTIVE MEK1/2 INHIBITOR; IQGAP1 INTEGRATES CA2+/CALMODULIN; NEGATIVE FEEDBACK-REGULATION; EFFECTOR DOMAIN PROTEIN; RASGAP-RELATED PROTEIN; EMBRYONIC STEM-CELLS; OF-FUNCTION MUTATION;
D O I
10.3390/biom13101555
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RAS-ERK pathway is a fundamental signaling cascade crucial for many biological processes including proliferation, cell cycle control, growth, and survival; common across all cell types. Notably, ERK1/2 are implicated in specific processes in a context-dependent manner as in stem cells and pancreatic beta-cells. Alterations in the different components of this cascade result in dysregulation of the effector kinases ERK1/2 which communicate with hundreds of substrates. Aberrant activation of the pathway contributes to a range of disorders, including cancer. This review provides an overview of the structure, activation, regulation, and mutational frequency of the different tiers of the cascade; with a particular focus on ERK1/2. We highlight the importance of scaffold proteins that contribute to kinase localization and coordinate interaction dynamics of the kinases with substrates, activators, and inhibitors. Additionally, we explore innovative therapeutic approaches emphasizing promising avenues in this field.
引用
收藏
页数:48
相关论文
共 50 条
  • [1] MAPK signalling: ERK5 versus ERK1/2
    Nishimoto, Satoko
    Nishida, Eisuke
    EMBO REPORTS, 2006, 7 (08) : 782 - 786
  • [2] Negative feedback regulation of the ERK1/2 MAPK pathway
    Lake, David
    Correa, Sonia A. L.
    Muller, Jurgen
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (23) : 4397 - 4413
  • [3] Negative feedback regulation of the ERK1/2 MAPK pathway
    David Lake
    Sonia A. L. Corrêa
    Jürgen Müller
    Cellular and Molecular Life Sciences, 2016, 73 : 4397 - 4413
  • [4] Dissecting MAPK pathway in BRAFmut melanoma: Intricacies of ERK1 and ERK2
    Zavorotinskaya, Tatiana
    Mehra, Upasana
    Dai, Yumin
    Faure, Michel
    Crawford, Ken
    Yu, Karen
    Cheng, Jan Marie
    Ma, Xiaolei
    Xuan, Jan
    Yan, Kelly
    Hekmat-Nejad, Mohammad
    Merritt, Hanne
    Stuart, Darrin
    Voliva, Charles
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Antioxidant enzyme expression is upregulated by 17 beta-estradiol via the ERK1/2 [MAPK]/NFκB cascade
    Borrás, C
    Gambini, J
    Gómez-Cabrera, MC
    Mann, GE
    Viña, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 : S120 - S120
  • [6] ALDOSTERONE MODULATES NCC INVOLVING MAPK ERK1/2 SIGNALING PATHWAY
    Feng, X.
    Wang, Y.
    Delpire, E.
    Gu, D.
    Cai, H.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 384 - 385
  • [7] Aldosterone modulates NCC involving MAPK ERK1/2 signaling pathway
    Feng, Xiuyan
    Wang, Yanhui
    Wu, Ping
    Delpire, Eric
    Gu, Dingying
    Cai, Hui
    FASEB JOURNAL, 2012, 26
  • [8] Identification of ERK1/2 mutations that confer resistance to MAPK pathway inhibitors
    Goetz, Eva M.
    Ghandi, Mahmoud
    Treacy, Daniel
    Wagle, Nikhil
    Garraway, Levi A.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [9] ERK1 and ERK2 MAPK are key regulators of distinct gene sets in zebrafish embryogenesis
    Krens, S. F. Gabby
    Corredor-Adamez, Maximiliano
    He, Shuning
    Snaar-Jagalska, B. Ewa
    Spaink, Herman P.
    BMC GENOMICS, 2008, 9 (1)
  • [10] The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage
    Wang, Xuening
    Pesakhov, Stella
    Harrison, Jonathan S.
    Kafka, Michael
    Danilenko, Michael
    Studzinski, George P.
    EXPERIMENTAL CELL RESEARCH, 2015, 330 (01) : 199 - 211